Radiation
For
"Wet" Macular Degeneration
Radiation
therapy can destroy blood vessels and prevent neovascularization.
Radiation is used after surgery to prevent scarring of the skin
(keloid) and during coronary bypass surgery to prevent stenosis
(scarring). This is because radiation can kill or effect the
cells which make up newly formed blood vessels, inflammatory
cells which promote scarring, and cells
which help create fibrous tissues.
Ophthalmologists have been using radiation to treat tumors within
the eye, thyroid eye disease, and more recently to treat "wet"
macular degeneration. Though numerous studies have suggested
that radiation might help patients with macular degeneration,
many other studies have suggested that it does not.
Bergink
et al have provided the best evidence that radiation can delay
vision loss after the onset of wet macular degeneration. He
performed a prospective-randomized, controlled clinical trial
comparing moderate doses of external beam irradiation to observation
(no treatment). They found that 30% of treated patients and
52% of nontreated patients lost 3 lines of vision after 1 year
of follow up. But the more dramatic comparison was at 6 lines
of vision loss. Only 22% of the radiation treated patients suffered
this severe loss of vision as compared 44% of the untreated
patients at 1 year follow up.
In
contrast, Holz recently reported on a large multicenter trial
of relatively low dose external radiation therapy. This study
concluded that 16 Gy in given over 8 days resulted in the same
vision in the treated and untreated patients at 1 years follow-up.
Both
of these studies are excellent, but Bergink's suffers from small
numbers (only 75 patients), and Holz concluded that they might
have used too little radiation.
Other
Forms of Radiation Therapy
You
may have heard of different forms of radiation. These may include:
Proton Beam, Strontium-90, Palladium-103, Radiosurgery, and
EBRT (external beam radiation therapy). The potential therapeutic
effects and side-effects of these different forms of radiation
differ due to their distributions of radiation to the macula
and normal ocular structures.
For
more information: Paul
T. Finger, MD.
1.
Bergink GJ, Hoyng CB van der Maazen RWM, et al. A randomized
controlled clinical trial on the efficacy of radiation therapy
in the control of subretinal choroidal neovascularization in
age-related macular degeneration: radiation versus observation.
Graefes Arch Clin Exp Ophthalmol 1998;236:321-325.
2.
Finger PT, Chakravarthy U. Radiotherapy as treatment for age-related
macular degeneration. Arch Ophthalmol 116:1507-1509, 1998.
A
Summary of Clinical Trials Using Radiation Therapy
Support
The EyeCare Foundation
Go
To Home
Please
report any problems to:webmaster@macular-degeneration.org
While this WWW site is intended to provide general information
as a public service, the content is not intended to represent
official policies and practices of the institution or to substitute
for health care provided by a clinician.
Content and design copyright© Paul
T. Finger,MD, FACS 1999-2003
ALL RIGHTS RESERVED